Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Biogen Idec Company Profile (NASDAQ:BIIB)

Consensus Ratings for Biogen Idec (NASDAQ:BIIB) (?)
Ratings Breakdown: 2 Hold Rating(s), 19 Buy Rating(s)
Consensus Rating:Buy (Score: 2.90)
Consensus Price Target: $387.39 (27.05% upside)

Current Analysts' Coverage Summary for Biogen Idec (NASDAQ:BIIB)
Show:
DateFirmActionRatingPrice TargetDetailsShare
11/24/2014Leerink SwannInitiated CoverageOutperform$370.00ViewTweet This Rating  Share This Rating on StockTwits
11/19/2014Credit SuisseLower Price TargetOutperform$425.00 -> $400.00ViewTweet This Rating  Share This Rating on StockTwits
11/6/2014ZacksUpgradeNeutral -> Outperform$383.00ViewTweet This Rating  Share This Rating on StockTwits
10/23/2014Citigroup Inc.Reiterated RatingBuy$387.00 -> $383.00ViewTweet This Rating  Share This Rating on StockTwits
10/22/2014RBC CapitalReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
10/22/2014Robert W. BairdUpgradeNeutral -> Outperform$382.00ViewTweet This Rating  Share This Rating on StockTwits
10/1/2014Bank of AmericaInitiated CoverageNeutral$371.00ViewTweet This Rating  Share This Rating on StockTwits
8/19/2014Stifel NicolausInitiated CoverageBuy$376.00ViewTweet This Rating  Share This Rating on StockTwits
8/18/2014Morgan StanleyReiterated RatingOverweight$395.00ViewTweet This Rating  Share This Rating on StockTwits
7/29/2014ArgusBoost Price TargetBuy$360.00 -> $385.00ViewTweet This Rating  Share This Rating on StockTwits
7/24/2014Deutsche BankReiterated RatingBuy$415.00 -> $430.00ViewTweet This Rating  Share This Rating on StockTwits
7/24/2014Jefferies GroupReiterated RatingBuy$380.00 -> $410.00ViewTweet This Rating  Share This Rating on StockTwits
7/24/2014BMO Capital MarketsBoost Price TargetOutperform$432.00 -> $474.00ViewTweet This Rating  Share This Rating on StockTwits
7/24/2014NomuraBoost Price TargetBuy$415.00 -> $424.00ViewTweet This Rating  Share This Rating on StockTwits
5/29/2014JPMorgan Chase & Co.UpgradeNeutral -> Overweight$300.00 -> $375.00ViewTweet This Rating  Share This Rating on StockTwits
5/27/2014OppenheimerReiterated RatingMarket PerformViewTweet This Rating  Share This Rating on StockTwits
3/7/2014BarclaysBoost Price TargetOverweight$325.00 -> $352.00ViewTweet This Rating  Share This Rating on StockTwits
3/3/2014TheStreetReiterated RatingPositive -> BuyViewTweet This Rating  Share This Rating on StockTwits
1/30/2014Brean CapitalBoost Price TargetBuy$293.00 -> $377.00ViewTweet This Rating  Share This Rating on StockTwits
1/27/2014Canaccord GenuityBoost Price TargetBuy$291.00 -> $355.00ViewTweet This Rating  Share This Rating on StockTwits
11/26/2013Piper JaffrayInitiated CoverageOverweight$331.00ViewTweet This Rating  Share This Rating on StockTwits
10/30/2013FBR & CoUpgradeUnderperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
10/30/2013FBR Capital MarketsInitiated CoverageMarket Perform$259.00ViewTweet This Rating  Share This Rating on StockTwits
10/29/2013GuggenheimBoost Price TargetNeutral$228.00 -> $247.00ViewTweet This Rating  Share This Rating on StockTwits
10/22/2013Wells Fargo & Co.Reiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
9/18/2013Goldman SachsBoost Price Target$220.00 -> $240.00ViewTweet This Rating  Share This Rating on StockTwits
7/10/2013Sanford C. BernsteinReiterated RatingMarket Perform$231.00ViewTweet This Rating  Share This Rating on StockTwits
5/29/2013Cowen and CompanyReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
5/20/2013Evercore ISIReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
5/9/2013MKM PartnersBoost Price TargetNeutral$208.00 -> $215.00ViewTweet This Rating  Share This Rating on StockTwits
4/24/2013JMP SecuritiesBoost Price TargetMarket Outperform$203.00 -> $240.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/26/2012 forward)